Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for recovery of brain structure and function in chronic cannabis users
ISRCTN89498802Phase 2Completed
- Sponsor
- University of Wollongong
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cannabidiol in cannabis use disorder (CUD), sponsored by University of Wollongong. Primary endpoints: Hippocampal volumetrics, Hippocampal neurochemical markers and 1 more. Started Jul 2015; status: completed.
02
Drugs
cannabidiol
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on ISRCTN89498802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN89498802.